CONSUMER CHOICE IN GLUCOSAMINE PRODUCTS

That this House notes the longstanding position of the Medicines and Healthcare Products Regulatory Agency that depending on the way in which glucosamine products are formulated and marketed, they may correctly be considered in some cases as food products and in others as medicinal products with a licence; appreciates that this approach has ensured consumer access to a wide range of safe and popular glucosamine products; fully supports the Agency's defence of its position against a challenge by one company that seeks to have all glucosamine products designated as medicines so driving up prices, reducing consumer choice and limiting the way in which the benefits of such products may be promoted; and encourages Consumers for Health Choice to keep up it's campaign to defend consumer choice in natural health products.